Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Total 13F shares
-
268,775,703
-
Share change
-
+20,189,209
-
Total reported value
-
$3,353,010,219
-
Put/Call ratio
-
93%
-
Price per share
-
$12.48
-
Number of holders
-
202
-
Value change
-
+$246,345,026
-
Number of buys
-
131
-
Number of sells
-
69
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q2 2019
As of 30 Jun 2019,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
202 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
268,775,703 shares.
The largest 10 holders included
Redmile Group, LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., JANUS HENDERSON GROUP PLC, Avoro Capital Advisors LLC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, JENNISON ASSOCIATES LLC, and Palo Alto Investors LP.
This page lists
202
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.